Table 2.
RBE values carbon ion/proton in prostate cancer cell lines
| Author, year | RBE model | RBE value |
|---|---|---|
| Konings 2019 | L–Q | PC-3: 0.94 (proton) and 1.93 (carbon ion) |
| Butterworth 2012 | Not reported | DU-145: 1.1 |
| Khachonkham 2020 | L–Q | DU-145: 1.28 ± 0.25, 1.37 ± 0.17 and 1.52 ± 0.17 (within SOBP); 1.27 ± 0.27, 0.97 ± 0.4 (before peak)a |
| Tinganelli 2013 | L–Q | RAT-1: 2.8 ± 0.2 (oxic) and 3.7 ± 0.1 (anoxic) |
| Polf 2011 | L–Q | DU-145: 1.3 (untreated) and 1.5 (Au-treated) |
| Suetens 2015 | L–Q | PC-3: 1.67 |
RBE relative biological effectiveness, L–Q linear–quadratic
a Data were from RBE10, RBE2Gy and RBE4Gy were not shown in this table